Pro Medicus Limited (OTCPK:PMCUF) Q4 2025 Earnings Conference Call August 13, 2025 9:00 PM ET
Company Participants
Clayton James Hatch – Chief Financial Officer
Sam Aaron Hupert – Co-Founder, CEO, MD & Executive Director
Conference Call Participants
Andrew Paine – CLSA Limited, Research Division
Annabel Li – Goldman Sachs Group, Inc., Research Division
Christine Trinh – Macquarie Research
David A. Low – JPMorgan Chase & Co, Research Division
Garry Sherriff – RBC Capital Markets, Research Division
John Hester – Bell Potter Securities Limited, Research Division
Josh Charles Kannourakis – Barrenjoey Markets Pty Limited, Research Division
Mathieu Chevrier – Citigroup Inc., Research Division
Operator
Thank you for standing by, and welcome to the Pro Medicus Limited Full Year Results Briefing. [Operator Instructions] I would now like to hand the conference over to Dr. Sam Hupert, CEO. Please go ahead.
Sam Aaron Hupert
Thank you. Good morning, everybody, and thanks for joining us for our FY ’25 full year results. As most of you know, we are leaders in enterprise imaging and radiology information systems. We work in 3 jurisdictions. Our group headquarter in Melbourne, Australia. Our R&D center and support center in Berlin. And our largest market, which is about 90% of our revenue from North America with our offices in San Diego.
We have 2 product lines in Australia. It’s the Visage RIS, which does more of the practice management, back office billing scheduling and Visage 7, which is a clinical product. It’s the radiologist desktop that they use to call up images, enhance them and make the diagnosis, and that’s the product we sell globally and particularly in the U.S.
In terms of our results, I think it’s fair to say that all of our key financial metrics moved materially in the right direction, revenue up just under 32%. Profit after tax, approximately
#Pro #Medicus #Limited #PMCUF #Earnings #Call #Transcript